| Date Filed | Type | Description |
| 08/03/2023 |
4
| Jenkins Annalisa (Director) has filed a Form 4 on COMPASS Pathways plc|
Txns:
| Paid exercise price by delivering 161 shares
@ $8.95, valued at
$1.4k
|
|
| 06/08/2023 |
4
| Jenkins Annalisa (Director) has filed a Form 4 on AVROBIO, Inc.|
Txns:
| Granted 17,643 options to buy
@ $1.09, valued at
$19.2k
|
|
| 06/06/2023 |
4
| Jenkins Annalisa (Director) has filed a Form 4 on COMPASS Pathways plc|
Txns:
| Granted 26,000 options to buy
@ $7.88, valued at
$204.9k
|
|
| 05/04/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| Jenkins Annalisa (Director) has filed a Form 4 on COMPASS Pathways plc|
Txns:
| Granted 17,000 options to buy
@ $9.41, valued at
$160k
|
|
| 06/10/2022 |
4
| Jenkins Annalisa (Director) has filed a Form 4 on AVROBIO, Inc.|
Txns:
| Granted 17,478 options to buy
@ $1.06, valued at
$18.5k
|
|
| 03/31/2022 |
4
| Jenkins Annalisa (Director) has filed a Form 4 on COMPASS Pathways plc|
Txns:
| Sold 3,384 shares
@ $12.48, valued at
$42.2k
|
|
| 01/03/2022 |
3
| Jenkins Annalisa (Director) has filed a Form 3 on COMPASS Pathways plc |
| 06/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2021 |
4
| Jenkins Annalisa (Director) has filed a Form 4 on AVROBIO, Inc.|
Txns:
| Granted 17,438 options to buy
@ $9.63, valued at
$167.9k
|
|
| 06/05/2020 |
4
| Jenkins Annalisa (Director) has filed a Form 4 on AVROBIO, Inc.|
Txns:
| Granted 14,000 options to buy
@ $21.91, valued at
$306.7k
|
|
| 06/17/2019 |
4
| Jenkins Annalisa (Director) has filed a Form 4 on ARDELYX, INC.|
Txns:
| Granted 20,072 shares
@ $0
Granted 50,000 options to buy
@ $2.74, valued at
$137k
|
|
| 06/13/2019 |
4
| Jenkins Annalisa (Director) has filed a Form 4 on AVROBIO, Inc.|
Txns:
| Granted 9,675 options to buy
@ $13.6, valued at
$131.6k
|
|
| 03/13/2019 |
4
| Jenkins Annalisa (Director) has filed a Form 4 on AgeX Therapeutics, Inc.|
Txns:
| Granted 100,000 options to buy
@ $4.28, valued at
$428k
|
|
| 11/27/2018 |
3
| Jenkins Annalisa (Director) has filed a Form 3 on AgeX Therapeutics, Inc. |
| 06/20/2018 |
3
| Jenkins Annalisa (Director) has filed a Form 3 on AVROBIO, Inc. |
| 06/15/2018 |
4
| Jenkins Annalisa (Director) has filed a Form 4 on ARDELYX, INC.|
Txns:
| Granted 13,399 shares
@ $0
Granted 15,000 options to buy
@ $4.03, valued at
$60.5k
|
|
| 11/07/2017 |
4
| Jenkins Annalisa (President and CEO) has filed a Form 4 on Dimension Therapeutics, Inc.|
Txns:
| Disposed/sold 481,696 options to buy
@ $0.56, valued at
$269.7k
Disposed/sold 74,375 options to buy
@ $3.57, valued at
$265.5k
Disposed/sold 342,113 options to buy
@ $4.09, valued at
$1.4M
Disposed/sold 160,000 options to buy
@ $7.14, valued at
$1.1M
Disposed/sold 192,000 options to buy
@ $1.9, valued at
$364.8k
Disposed/sold 150,000 options to buy
@ $1.35, valued at
$202.5k
|
|
| 09/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/05/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/12/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/06/2016 |
4
| Jenkins Annalisa (Director) has filed a Form 4 on ARDELYX, INC.|
Txns:
| Granted 15,000 options to buy
@ $9.27, valued at
$139.1k
|
|